CTT Pharmaceuticals Overview

  • Founded
  • 2013
Founded
  • Status
  • Public
  • Employees
  • 2
Employees
  • Stock Symbol
  • CTTH
Stock Symbol
  • Share Price
  • $0.06
  • (As of Friday Closing)

CTT Pharmaceuticals General Information

Description

CTT Pharmaceutical Holdings Inc is a development stage company specializing in drug delivery systems technology within the pharmaceutical industry. It focuses on fast-dissolving drug delivery systems through the development of advanced oral delivery thin wafers. The thin wafers are infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternative to smoking and ingestion. Its products include Medwafe, Cannawafe, Vetwafe, and others.

Contact Information

Formerly Known As
Mindesta
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare Technology Systems
Other Industries
Drug Discovery
Drug Delivery
Stock Exchange
PINX
Primary Office
  • 35 Galbraith Drive
  • Stoney Creek, Ontario L8G 1Z7
  • Canada
+1 (800) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CTT Pharmaceuticals Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.06 $0.05 $0.03 - $0.26 18.9K

CTT Pharmaceuticals Financials Summary

In Thousands,
USD
TTM 30-Sep-2016 FY 2015 31-Dec-2015 FY 2014 31-Dec-2014 FY 2013 31-Dec-2013
EV 807 309 9,001 51
Revenue 0 0 0 0
EBITDA (1,056) (1,446) 228 (19)
Net Income (1,056) (1,446) 228 (19)
Total Assets 45 644 1,662 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

CTT Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore CTT Pharmaceuticals‘s full profile, request access.

Request a free trial

CTT Pharmaceuticals Executive Team (5)

Name Title Board Seat Contact Info
Pankaj Modi Ph.D President, Chief Executive Officer & Chief Scientific Officer
Robert Allen Chief Financial Officer
Dean Hanisch Treasurer, Director & Secretary
Gregory Bowes Chief Executive Officer & Chief Financial Officer, Finance
To view CTT Pharmaceuticals’s complete executive team members history, request access »

CTT Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CTT Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore CTT Pharmaceuticals‘s full profile, request access.

Request a free trial